about
A Temporal Model of Human IgE and IgG Antibody FunctionThe effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokineticsCTLA-4 blockade: therapeutic potential in cancer treatmentsHuman monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthraxThe Production Processes and Biological Effects of Intravenous ImmunoglobulinEngineering a Monomeric Fc Domain Modality by N-Glycosylation for the Half-life Extension of BiotherapeuticsThe MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humansPopulation pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patientsThe mechanism of intestinal uptake and transcellular transport of IgG in the neonatal ratPharmacokinetic characteristics of therapeutic antibodies.Population pharmacokinetic data analysis of three phase I studies of matuzumab, a humanised anti-EGFR monoclonal antibody in clinical cancer developmentThe Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infectionsImmunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Behaviour of two IgG subclasses in transport of immunoglobulin across the human placenta.Antibody responses during hepatitis B viral infection.Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population.Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis.Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its inteaction with an IgG-reactive monoclonal IgMOntogeny and distribution of Fc gamma receptors in the human placenta. Transport or immune surveillance?Simulation of monoclonal antibody pharmacokinetics in humans using a minimal physiologically based model.Linking influenza virus tissue tropism to population-level reproductive fitnessThe relationship between L-chain synthesis and gamma-globulin production.Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.Human fibronectin metabolismSelection of nanobodies that target human neonatal Fc receptor.Exploring the immunoproteome for ovarian cancer biomarker discovery.Phagocytic, opsonic and immunoglobulin studies in newborns.Increased levels of IgG antibodies against human HSP60 in patients with spondyloarthritis.Maternal vaccination: moving the science forward.Quantitative abnormalities of allotypic genes in families with primary immune deficienciesExploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.Rapid polyclonal desensitization with antibodies to IgE and FcεRIαHinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3).Antibody-based protection against HIV infection by vectored immunoprophylaxisA Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties.Predicting the F(ab)-mediated effect of monoclonal antibodies in vivo by combining cell-level kinetic and pharmacokinetic modellingTolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjects.
P2860
Q21131207-C244B3FC-F450-4231-8FBA-8ABF56E053B0Q24561800-480772A8-1EC7-4787-95B0-6D926D176F4CQ24622666-BD0F4527-C18F-48C9-93A6-E5EAF58C3B4AQ24682011-C52CCD3D-F768-4DDA-93F2-024F59FDFB7EQ26752540-3056680A-9E0E-4C3B-BD1B-D0EBAB23C144Q27677555-C2C11326-F01B-47C2-8F2A-7F431325D10EQ28208533-86B17068-EC28-4272-9F84-EC0F0727846AQ28361034-271278A5-1D45-46AA-BE75-6A0A44FE8415Q29027111-E5543BE4-85F2-4B58-9C39-38D68D0E3EE8Q30316517-CE1B4A7D-DBC0-4225-BF84-663421680C7BQ31148686-B17B4485-D5CC-4698-9DE3-CCD019A4EF38Q33587496-01676D17-43F5-44C5-93F0-E6615D6C484EQ33843554-807332A1-9617-4911-A89F-A50E4235BD3CQ33867651-ED4F417B-D620-4352-93CC-FD87D38A58BFQ33881930-28946373-053C-47E8-810B-042E80358B9EQ33981600-3E687269-1D6A-4144-BC36-41974A66A86BQ33997525-7BEBCD7A-8784-49F9-89C3-A61B65057CE7Q34044438-C87F1A6C-91F6-4D8D-8B7C-81117AF2BB8AQ34058073-0B027C9B-2121-4710-AF7E-47A762F3DD28Q34060101-3AF7B797-38F2-4EAB-97D0-AD8E5C2DF4AFQ34087442-4AEA266F-D037-4BCA-B6A3-39B6CF167ADFQ34099756-B1A56CC4-EC6F-411F-A121-99FE83B6663EQ34404965-2977D4C5-E909-4F6A-91E9-BB8953B1910DQ34503635-26DDE66F-9A31-458A-9D6E-13607A301AB7Q34515219-7A552022-AE89-4405-9A8C-895AD415954BQ34529911-1C84DA4E-4368-4984-B11E-C3E1199D8481Q34541825-7DF8C1BC-E284-40FB-9E50-AAFC752F3CEAQ34560808-94DA4030-640E-4318-ABCC-9B82CB00A306Q34578119-EBCA775A-3910-450B-B1D3-C227156D0CF5Q34584552-62CB7F1E-FA82-485E-BAFF-4CB75AC7EF59Q34592752-E9D5E93E-ABB1-48BC-A267-6F8306C78739Q34630952-3BC56354-1093-4EE6-87F5-4C1B13427A73Q34713827-0616026C-1E48-41A1-8C97-C64F2B5BE081Q34869927-8B815339-4A03-45B2-9362-FF5E2408F406Q35125056-2E5F20FA-FA1E-41B1-A413-0D0C439164F9Q35583369-0C69E5CA-C7CF-4621-B2B7-72428B423099Q35658856-78B3E3AD-CBCF-4211-A360-FA857125AD8CQ35796700-A5B54A4A-FE60-4EA1-8C5E-A06373ADAC10Q35905876-BD8B5968-7F31-4F4A-87AA-2A5B2F7DEE93Q35918874-BC9E302F-8540-4036-BE59-2A64FED78072
P2860
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年論文
@yue
1970年論文
@zh-hant
1970年論文
@zh-hk
1970年論文
@zh-mo
1970年論文
@zh-tw
1970年论文
@wuu
1970年论文
@zh
1970年论文
@zh-cn
name
Metabolic properties of IgG subclasses in man.
@ast
Metabolic properties of IgG subclasses in man.
@en
type
label
Metabolic properties of IgG subclasses in man.
@ast
Metabolic properties of IgG subclasses in man.
@en
prefLabel
Metabolic properties of IgG subclasses in man.
@ast
Metabolic properties of IgG subclasses in man.
@en
P2093
P2860
P356
P1476
Metabolic properties of IgG subclasses in man.
@en
P2093
P2860
P304
P356
10.1172/JCI106279
P407
P577
1970-04-01T00:00:00Z